Growth Hormone-Releasing Peptide 2 (GHRP-2) was developed by Dr.C.Y. Bowers in 1993 and functions as a growth hormone secretagogue by increasing the release of GH from the pituitary gland. Approved in Japan in 2005 as GHRP Kaken 100 Injection, it has been used for diagnosing growth hormone deficiency and has gained recognition for promoting fat reduction and muscle growth, and for all its benefits often used by athletes.
Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.
Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.
For detailed information about GHRP-2 by Hilma Biocare, consult with your doctor or healthcare professional.
Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.
Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.
Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.